Search Results - "Rajec, J"

Sunitinib in the treatment of tubulocystic carcinoma of the kidney. A case report by Mego, M., Sycova-Mila, Z., Rychly, B., Obertova, J., Rajec, J., Hes, O., Mardiak, J., Rejlekova, K.

Get full text

Adenocarcinoma of the rete testis - a rare case of testicular malignancy by Chovanec, M, Mego, M, Sycova-Mila, Z, Obertova, J, Rajec, J, Palacka, P, Mardiak, J

“…Adenocarcinoma of rete testis is an extremely rare dia-gnosis described in around 70 patients worldwide. The prognosis of the disease in metastatic stage is…”
Get more information

Kinetics of tumor marker decline as an independent prognostic factor in patients with relapsed metastatic germ-cell tumors by Mego, M, Rejlekova, K, Reckova, M, Sycova-Mila, Z, Obertova, J, Rajec, J, Mardiak, J

“…Early serum tumor marker decline (STMD) during chemotherapy was shown to predict survival in patients with poor prognosis non-seminomatous germ cell tumors…”
Get more information

Prognostic factors in patients with relapsed or primary refractory germ cell tumors by Rejlekova, K, Mego, M, Sycova-Mila, Z, Obertova, J, Rajec, J, Salek, T, Mardiak, J

“…The aim of the study was to define prognostic factors of overall and event- free survival in patients with germ cell tumors progressing after platinum-based…”
Get more information

A rare case of malignant extragonadal germ cell tumor in the pineal region with an aggressive behaviour by Rejlekova, K, Mego, M, Rajec, J, Sycova-Mila, Z, Obertova, J, Mardiak, J

“…Though germ cell cancer is rare, it is the most common cancer in males between 20 and 40 years. The primary site for the development of germ cell tumor is…”
Get more information

Paraneoplastic Cushing's syndrome as the first sign of progression of prostate cancer by Rajec, J, Mego, M, Sycova-Mila, Z, Obertova, J, Brozmanova, K, Mardiak, J

“…Cushing's syndrome accompanying the small cell de-differentiation of the prostatic adenocarcinoma is a relatively rare clinical entity, associated with poor…”
Get more information

Biochemical evaluation of the antiplatelet effect of aspirin in patients at different levels of cardiovascular risk by Rajec, J, Kriska, M, Vojtko, R, Dukat, A, Risnyovszki, Z, Sapak, M

“…The phenomenon called aspirin resistance is being intensively discussed. To evaluate the biochemical aspirin response, the method of urinary 11-dehydro TXB2…”
Get more information

Endothelaemia--a marker of vascular damage by Rajec, J, Tisonova, J, Kriska, M, Kristova, V, Vojtko, R, Dukat, A, Ambrozy, E, Slysko, R, Varga, I

“…The aim of the study was to determine the amount of circulating endothelial cells (CECs) in patients with an advanced cardiovascular (CV) disease, compare the…”
Get more information

Perception of drug risk in the database of Drug Information Centre in Bratislava by Lassanova, M, Rajec, J, Lassan, S, Tisonova, J, Kunzo, M, Wawruch, M, Bozekova, L, Kriska, M, Kristova, V

“…The aim of the presented study was to analyse the types and quantity of inquiries received at Drug Information Centre in Bratislava during the period from May…”
Get more information

Laparoscopic-asisted percutaneus endoscopic cecostomy (LAPEC) in the treatment of severe constipation of adults - single center study by Husťak, R, Škuta, R, Dobrovodský, A, Habiňák, M, Kudlová, D, Janegová, A, Plavčanová, E, Rajec, J, Martínek, J

“…Effective treatment for chronic constipation is a real clinical challenge, especially in patients with severe symptoms. If conservative measures do not help,…”
Get more information

Survival is associated with circulating cytokine levels in metastatic testicular germ cell tumors by Svetlovska, D., Miskovska, V., Cholujova, D., Gronesova, P., Cingelova, S., Chovanec, M., Sycova-Mila, Z., Obertova, J., Palacka, P., Rajec, J., Kalavska, K., Usakova, V., Luha, J., Ondrus, D., Spanik, S., Mardiak, J., Mego, M.

Get full text

Phase II Study of Everolimus (E) in Refractory Germ Cell Tumors (GCTS) by Reckova, M., Mego, M., Svetlovska, D., Miskovska', V., Obertova, J., Sycova-Mila, Z., Palacka, P., Rajec, J., Liskova, S., Mardiak, J.

Get full text

Adjuvant high-dose IFN-alfa2b real life treatment outcome in the patients with malignant melanoma by Hlavata, Z., Salek, T., Dolinsky, J., Porsok, S., Rajec, J., Mardiak, J.

“…Abstract only…”
Get full text

Determination of efficacy of TIP combination (paclitaxel, ifosfamide, cisplatin) as first salvage therapy for patients with relapsed germ cell tumors in a poor prognosis group by Mardiak, J., Rejlekova, K., Mego, M., Rajec, J., Sycova-Mila, Z., Obertova, J., Salek, T., Reckova, M.

“…Abstract only e16049 Background: The efficacy of TIP appears to be suitable salvage therapy for patients with relapsed germ cell tumors (GCTs) with good…”
Get full text

Is the same tyrosine kinase inhibitor still effective after development of brain metastases? A Case report by Obertova, J, Mego, M, Palacka, P, Rajec, J, Chovanec, M, Mardiak, J

“…There is a new era of treatment options since introduction of new biological targeted therapies (tyrosine kinase inhibitors (TKIs) and mammalian target of…”
Get more information

Sunitinib in the treatment of tubulocystic carcinoma of the kidney. A case report by Mego, M, Sycova-Mila, Z, Rejlekova, K, Rychly, B, Obertova, J, Rajec, J, Hes, O, Mardiak, J

Get full text